Vivos Therapeutics (VVOS)
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025
ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results
Agilent Technologies, Inc. - Agilent Announces Cash Dividend of 25.5 Cents Per Share
Baxter - Baxter Announces Increase in Maximum Tender Cap for 1.915% Senior Notes Due 2027
Vicarious Surgical Inc. - Vicarious Surgical to Participate in the Piper Sandler 37th Annual Healthcare Conference
Vicarious Surgical to Participate in the Piper Sandler 37th Annual Healthcare Conference
Baxter Announces Increase in Maximum Tender Cap for 1.915% Senior Notes Due 2027
Agilent Announces Cash Dividend of 25.5 Cents Per Share
EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference